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Abstract
Purpose Anterior cervical discectomy with fusion is a
common procedure for treating radicular arm pain.
Polyetheretherketone (PEEK) plastic is a frequently used
material in cages for interbody fusion. Silicon nitride is a
new alternative with desirable bone compatibility and
imaging characteristics. The aim of the present study is to
compare silicon nitride implants with PEEK cages filled
with autograft harvested from osteophytes.
Methods The study is a prospective, randomized, blinded
study of 100 patients with 2 years follow-up. The primary
outcome measure was improvement in the Neck Disability
Index. Other outcome measures included SF-36, VAS arm
pain, VAS neck pain, assessment of recovery, operative
characteristics, complications, fusion and subsidence based
on dynamic X-ray and CT scan.
Results There was no significant difference in NDI scores
between the groups at 24 months follow-up. At 3 and
12 months the NDI scores were in favor of PEEK although
the differences were not clinically relevant. On most fol-
low-up moments there was no difference in VAS neck and
VAS arm between both groups, and there was no statisti-
cally significant difference in patients’ perceived recovery
during follow-up. Fusion rate and subsidence were similar
for the two study arms and about 90% of the implants were
fused at 24 months.
Conclusions Patients treated with silicon nitride and PEEK
reported similar recovery rates during follow-up. There
was no significant difference in clinical outcome at
24 months. Fusion rates improved over time and are
comparable between both groups.
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Introduction
Anterior cervical discectomy and fusion (ACDF) is a
common treatment for a cervical radicular syndrome pro-
ducing persistent arm pain with or without neck pain. The
choices for anterior cervical fusion are many, and a recent
literature review has described the lack of clarity on the
best procedure options for ACDF [1]. To maintain or
enlarge the disc space height and maintain lordosis a block
of autograft is frequently inserted into the disc space [2, 3].
However, graft harvest for cervical interbody fusion can be
associated with pain at the iliac crest harvest site [1].
Interbody fusion cages made of metal, plastic and most
recently ceramic materials have been shown to have
advantages over autograft bone blocks: (1) using a cage
provides strength to support a larger axial load than bone;
(2) the cage can be filled with locally harvested autograft
(from osteophytes) or bone graft substitutes, eliminating
the need for harvest from the iliac crest, and finally, (3)
using a cage saves time in the procedure, reduces blood
loss and reduces post-operative pain compared with
obtaining graft from the iliac crest.
Despite a paucity of data supporting choice of cage
materials [4], plastic cages made from polyetheretherke-
tone (PEEK) have become a popular method for stabilizing
the disc space after ACDF [5–8]. PEEK as a biomaterial
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has some attractive properties and some liabilities [9]. It
has a modulus of elasticity similar to bone. PEEK is
hydrophobic and develops a mild fibrous tissue reaction
around implants. While it is radiolucent and causes no
distortion of X-ray, CT or MR images, the lucency makes it
difficult to evaluate cage position and fusion. This problem
is partially overcome by inserting radiopaque metal
markers into PEEK cages.
In order to address the deficiencies of autograft blocks,
implant manufacturers have evaluated additional materials
including ceramics. Ceramic materials are attractive
because they are generally biocompatible and have desir-
able imaging properties. The toughest and most stable ce-
ramic is silicon nitride (Si3N4). Silicon nitride cages have
been tested extensively in cadavers, demonstrating desir-
able imaging characteristics [10], and in animals demon-
strating biocompatibility and bacteriostatic properties
[11, 12]. Amedica Corporation (Salt Lake City, UT, USA)
has designed spacers made from an outer shell of dense
silicon nitride and a center filled with a microporous form
of the same material (Valeo CCsC silicon nitride spacers)
(Fig. 1). In a sheep model, these spacers demonstrated
robust bone ingrowth resulting in fusion [13].
Because PEEK cages have become the gold standard for
cervical interbody fusion, the CAncellous Structure
Ceramic Arthrodesis DEvice (CASCADE) trial was
designed to compare stand-alone silicon nitride spacers
filled with microporous silicon nitride to PEEK cages filled
with autograft harvested from osteophytes. This article
reports the clinical and radiological outcome of patients
treated with silicon nitride versus PEEK and is the first
paper of human outcomes using silicon nitride cages.
Materials and methods
The study protocol has been published in detail previously
[14] and a summary is available on the clinicaltrials.gov
website (ClinicalTrials.gov Identifier: NCT01511445). The
trial is also registered in the Netherlands (NL
36013.098.11). Briefly, the study was designed as a
prospective, single-blind randomized controlled compar-
ison of single-level ACDF using Valeo CCsC silicon nitride
spacers versus PEEK cages. Initial analysis was performed
when all patients reached 1 year follow-up, and final
analysis was conducted when all patients had 2 years fol-
low-up. The study was approved by the Medical Ethics
Committee of Southwest Holland. Informed consent was
obtained from all individual participants included in the
study. The patients were treated by two neurosurgeons of
Haaglanden Medical Center, The Hague, Netherlands (MA
and JW).
The inclusion and exclusion criteria are similar to other
ACDF randomized trials using PEEK cages as control
groups [15, 16] (Table 1). Patients were included if they
presented with radicular symptoms in one or both arms
indicating a single nerve root involvement with or without
medullary symptoms and with or without neck pain. The
diagnosis of a herniation with or without osteophytes at a
single level was confirmed radiographically. Exclusion
criteria included previous cervical surgery, severe kyphosis
at the involved level, neck pain only without radicular or
medullary symptoms, metabolic disease, neoplasms, cer-
vical trauma, spinal anomalies, severe mental or psychi-
atric disease, and inadequate Dutch language.
Randomization (1:1 ratio of silicon nitride spacers to
PEEK cages) was carried out in the operating room after
anesthesia was induced by opening sequentially numbered,
sealed envelopes that were prepared by the data manager.
The randomization order was determined using a random
number generator to produce random blocks of four, six
and eight numbers. Patients were blinded to the group
allocation during the first year of follow-up.
Surgical procedure
A standard right-side approach was made after confirming
the level on fluoroscopy. A standard anterior discectomy
Fig. 1 Valeo CCsC silicon nitride cervical interbody fusion device
used in the CASCADE trial with radiographic characteristics
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was performed with the aid of loupe magnification or
operating microscope, depending on the preference of the
surgeon. After complete decompression, the allocated
spacer or cage was implanted. Silicon nitride spacers
(Amedica Corporation, Salt Lake City, UT, USA) were
wetted with patient blood from the operative field but had
no other filler. PEEK cages (Medicrea Manta, Lyon,
France) were filled with local autograft obtained from
osteophytes at the operative level. No patients had auto-
graft or any other substance placed outside the spacers or
cages, and no patients had supplemental fixation such as
plates and screws. The spacers and cage sizes were chosen
to incorporate the largest possible footprint; the typical
cage was 17 mm wide by 14 mm in depth. The silicon
nitride implants had parallel superior and inferior surfaces,
while the PEEK cages had 3 of lordosis. After surgery, all
patients were mobilized as soon as possible without a
collar.
Primary non-inferiority hypothesis
The primary effectiveness hypothesis, as stated in the
Clinical Trial Protocol, is that there is no difference in
Neck Disability Index (NDI) improvement between the two
study arms. This hypothesis was formulated for testing
clinical non-inferiority based on the Blackwelder approach
[17]. In the Blackwelder approach, the null hypothesis is
that the investigational device is clinically significantly
worse than control by an amount (at least) equal to an a
priori selected non-inferiority margin. The minimal clini-
cally important difference (MCID) for the NDI is 7.5 points
out of 50, or 15% when the scale is standardized to a range
from 0 to 100 [18]. Therefore, the primary null hypothesis
is that the mean improvement for the investigational device
is smaller (i.e., less negative) than the mean improvement
for the control device by an amount equal to or exceeding
15 out of the 100-point scale.
Sample size determination
The sample size was calculated with 90% power to detect a
difference in NDI improvement equal to the MCID of 15%,
the non-inferiority margin. The sample size calculation
used the improvement amount and standard deviation
observed in a previous study of carbon fiber-reinforced
PEEK cages [19]. The calculated sample size was 46
patients in each group, and an additional 4 patients were
added to each group to allow 8% for loss to follow-up.
Outcome measures
The primary outcome measure is improvement in the NDI
which has been translated into Dutch and validated for the
population of the Netherlands [20, 21]. Secondary outcome
measures were the 100-mm visual analog scale (VAS) for
arm pain and neck pain [22], the 7-point Likert self-rating
Table 1 Inclusion and exclusion criteria
Inclusion criteria
Age 18–75 years
Radicular signs and symptoms in one or both arms (i.e., pain, paresthesia or paresis in a specific nerve root distribution) or symptoms and
signs of acute or chronic myelopathy
At least 8 weeks prior conservative treatment (i.e., physical therapy, pain medication)
Radiographic diagnosis of cervical disc herniation and/or osteophyte at 1 level (C3–C4 to C7–T1) in accordance with clinical signs and
symptoms
Ability and willingness to comply with project requirements
Written informed consent given by the subject or the subject’s legally authorized representative
Exclusion criteria
Previous cervical surgery (either anterior or posterior)
Increased motion on dynamic studies ([3 mm)
Severe segmental kyphosis of the involved disc level ([7)
Patient cannot be imaged with MRI
Neck pain only (without radicular or medullary symptoms)
Infection
Metabolic and bone diseases (osteoporosis, severe osteopenia)
Neoplasma or trauma of the cervical spine
Spinal anomaly (Klippel Feil, Bechterew, OPLL)
Severe mental or psychiatric disorder
Inadequate Dutch language
Planned (e)migration abroad in the year after inclusion
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scale for perceived recovery in which ‘‘complete recovery’’
and ‘‘almost complete recovery’’ are defined as good out-
come [23], and the generic health survey on the Short
Form-36 (SF-36) [24, 25]. Adverse events, reoperations,
and surgical complications were also recorded.
Radiological assessment
At each follow-up time point, four plane films were col-
lected (standing anterior–posterior, lateral, flexion and
extension radiographs). A thin-slice CT scan was also
collected at the 6 months follow-up. In addition, quantita-
tive and qualitative motion analysis using Medical Metrics,
Inc. (MMI, Houston, TX, USA) software [26] allowed
measurement of rotation on flexion–extension films with an
accuracy of ±1. Images for each follow-up time point
were provided on compact disks for analysis by MMI.
Fusion for this study was defined as rotation B4 and
B1.25 mm translation on flexion–extension films. The
dynamic X-ray and CT at 6 months follow-up were also
used to measure cage migration and subsidence. Radiolo-
gists quantified bone bridging around implants, bone
bridging through the PEEK cage and lucencies around both
types of implant.
Statistical analysis
The statistical analysis plan was modified from the pub-
lished protocol to meet FDA recommendations for a
prospective study prior to the completion of data collec-
tion. Pre-operative data were analyzed for all randomized
patients. The Fisher’s exact test (two-sided) was used for
categorical variables, while the Wilcoxon rank sum test
was used for continuous variables. Missing values in the
non-inferiority analysis were conservatively filled using the
last value carried forward method.
Results
Between December 2011 and October 2013, 104 of 390
eligible patients were enrolled in the randomized trial. Four
patients were censored because of protocol violations
(surgery by non-investigators). All presented data are per-
formed on the intention-to-treat analysis of 100 patients.
The complete study patient accountability flowchart is
presented in Fig. 2. Fifty-two patients were randomized for
silicon nitride and 48 patients for PEEK. Baseline char-
acteristics for both groups were similar (Table 2). The only
statistical difference was seen in the level of treatment with
significantly more patients in the silicone nitrate group
having surgeries in the lower cervical spine C6C7 and
C7T1. Over 40% of the study subjects were smokers. There
were no crossovers or allocation errors. At 24 months
follow-up, data from 96 patients were available.
Clinical outcome
Primary outcome measure
Patients in both study arms showed large improvements in
NDI scores during the 24-month follow-up. Patients treated
with PEEK had significantly better improvement at
3 months and 12 months, although these differences were
less than the MCID for the NDI of 7.5 points. There was no
significant difference in NDI score at 2 years (Fig. 2).
Other outcome measures
VAS arm pain and VAS neck pain improved in both
groups, although there was a significant difference in arm
pain at 12 months and neck pain at 3 months, both favoring
PEEK. These differences did not reach the MCID of
20 mm and were therefore not clinically relevant. Of all
SF-36 domains, only Bodily Pain at 3 months follow-up
had a statistically significant difference, favoring PEEK
patients. The patients’ reported perceived recovery
improved during the follow-up moments; 78% of the sili-
con nitride patients and 88% of the PEEK patients reported
good outcome at 24 months (p[ 0.05). All secondary
outcome measures are illustrated in Table 3.
Complications and re-operations
The surgical procedures and hospital stay were uneventful
for almost all patients (Table 4). There was no difference
in operative time, estimated blood loss, or length of stay
between the two groups. Two PEEK patients and one sil-
icon nitride patient had incidental durotomies which were
repaired intra-operatively and had no permanent sequelae.
Fig. 2 Neck and Disability Index scores during follow-up of
24 months. At 3 and 12 months there were small significant
differences in favor of PEEK, although not clinically relevant
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Nine silicon nitride and eight PEEK patients had transient
dysphagia, with or without hoarseness. One patient in each
group had recurrent symptomatic nerve root compression
at the index level because of substantial subsidence. In both
cases, the device was replaced by an allograft block and the
patient had supplemental fixation with a plate and screws.
One silicon nitride patient had a deep wound infection
requiring debridement without spacer removal and the
patient was treated with antibiotics. During the follow-up
period of 2 years, nine patients had revision surgery at the
adjacent level whereby disc herniations or osteophytes
were removed; six in the silicon nitride group and three
patients in the PEEK group. The average time from the
index surgery to the secondary adjacent level surgery was
12.6 months for silicon nitride patients and 11.3 months
for PEEK cage patients.
Fusion and subsidence
Based on the MMI analysis of flexion/extension motion
B4, there was no significant difference in fusion rate
between silicon nitride and PEEK. In both groups the
fusion rate increased over time and improved from 66% at
3 months follow-up, to 90% at 24 months follow-up for
both groups (Fig. 3). At 6 months follow-up, 26 patients
treated with silicon nitride and 27 patients treated with
PEEK showed some degree of subsidence at flexion/ex-
tension images and CT. The mean subsidence was
1.48 mm for silicon nitride and 1.59 mm for PEEK, and
the difference was not statistically significantly different
(Table 5).
Discussion
The CASCADE trial was designed to compare microp-
orous silicon nitride as a spacer material versus the gold
standard of PEEK filled with autograft. It was modeled
after ongoing trials comparing anterior discectomy with
ACDF and decompression plus cervical artificial discs
[15, 16]. In those trials, the ACDF procedure used PEEK
cages filled with a beta tricalcium phosphate synthetic graft
material. The use of local autograft in the CASCADE trial
raises the threshold for non-inferiority because autograft
produces have a higher fusion rate [27]. Based on the
CASCADE trial, patients treated with silicon nitride and
patients treated with PEEK cages reported similar recovery
rates and improvement in NDI during follow-up with
similar fusion rates. However, some intermediate results
were in favor of PEEK, but these differences did not reach
the level of the minimal clinically important difference and
therefore had no clinical relevance.
The main source of pain relief in the procedure of
anterior cervical discectomy is decompression of the nerve
root by removing the herniated disc and/or osteophytes.
Numerous studies on ACDF have demonstrated satisfac-
tory clinical and radiological results in the majority of
patients [1, 8, 28–30]. Even in the older population ACDF
surgery will result in a significant gain in health-state utility
[31]. Adding an interbody implant to the anterior discec-
tomy procedure is primarily to stabilize the height and
angulation of the disc space. Loss of height could lead to
recurrent stenosis of the foramen and recurrence of radic-
ular pain. Even empty cages are associated with
Table 2 Baseline
demographics of 100 analyzed
patients (4 were excluded
because of protocol violation)
Demographics Silicon nitride (N = 52) PEEK (N = 48) p value
Female gender (%) 23 (44%) 23 (48%) 0.84
Mean age in years (range) 53.3 (34–74) 49.4 (28–67) 0.11
Symptoms
Radicular pain only 48 39
Medullary only 2 7
Combined 3 5
Symptomatic level 0.03
C3C4 1 (2%) 1 (2%)
C4C5 0 (0%) 6 (13%)
C5C6 30 (58%) 30 (63%)
C6C7 19 (37%) 10 (21%)
C7T1 2 (4%) 1 (2%)
Smoking 24 (46%) 19 (40%) 0.55
Mean BMI (range) 26.7 (19.4–39.1) 28.6 (20.6–75) 0.18
NDI (±SD) 42.6 ± 17.1 42.8 ± 14.9 0.96
SF-36 physical function 59.4 ± 17.9 55.3 ± 24.5 0.56
SF-36 bodily pain 37.7 ± 23.5 34.5 ± 20.9 0.55
SF Short Form, SD standard deviation, BMI Body Mass Index
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improvement in pain and disability and remarkable high
fusion rates are documented [29, 32].
A recently published randomized controlled trial on
acrylic cages versus PEEK cages documented significant
clinical and radiological improvement in favor of acrylic
cages [28]. The study suggests more cost effectiveness of
acrylic implants compared to PEEK, although it is limited
by small patient numbers and short-term follow-up.
Therefore, in our opinion, the development of new implant
technologies is better understood as long as the ultimate
and optimal implant has not been defined yet.
In our trial, patients reported similar recovery rates
during follow-up regardless of the type of implant. With
composite clinical success defined as at least 15-point
improvement of NDI (out of 100), fusion determined on
dynamic X-rays, and no revision surgery at the index level,
62% of silicon nitride and 69% of PEEK achieved com-
posite clinical success at 2 years (p = 0.64). At 2 years
follow-up, there was no difference in revision surgery of
the index level between silicon nitride and PEEK. How-
ever, patient treated with silicon nitride were operated
more frequently at the adjacent level (N = 6) than patients
who had implanted PEEK (N = 3). The complaints of
these patients at follow-up visits and their perceived
recovery scores were most likely influenced by the devel-
opment of adjacent segment symptoms. In all cases, these
patients had evidence of degeneration at the adjacent level,
but no related symptoms at the time of the index procedure.
Possibly, the initial clinical presentation was already based
on symptomatology of both levels which could also explain
difference in intermediate outcome measures. In addition,
the silicon nitride cages were parallel in design while the
PEEK cages had 3 of lordosis. It has been hypothesized
that the parallel cages might present a theoretical distur-
bance of the sagittal balance which could explain the early
presentation of adjacent level disease in the silicon nitride
patients.
Microporous materials to fill cages are an attractive
concept since no autograft harvest or additional expense for
cage filler materials is needed. Trabecular metal made from
porous tantalum has received extensive testing, but has not
fared well as a stand-alone cage material because it lacks
strength (leading to fragmentation) and its high radio-
opacity and metallic distortion interferes with imaging
[33]. Silicon nitride spacers, however, did not suffer from
these problems. There were no device integrity issues and
imaging was not affected by the silicon nitride product.
Animal studies [11] of silicon nitride implants have
shown that there is no foreign body encapsulation as is
noted with PEEK cages [9]. This attribute apparently
makes the material more bacteriostatic. In our study, one
infection of a silicon nitride spacer was successfully deb-
rided without spacer removal, resulting in a successful
clinical outcome and fusion. While infections are rare and
therefore difficult to study, the bacteriostatic properties of
silicon nitride implants may allow patients to recover from
inadvertent wound contamination without implant removal.
This possibility will only be proven by collection of a large
amount of patient data through a registry or meta-analysis.
The design of the CASCADE trial had several limitations.
The moderate sample size restricted the amount of subgroup
analysis that could be performed. The selection of PEEK
cages with autograft harvested from osteophytes as a control
group is not the most widely used control in ACDF studies;
Table 3 Treatment effect of primary and secondary outcome during
follow-up period
Silicon nitride PEEK p value
Neck Disability Index
3 months 27.7 ± 18.5 20.7 ± 14.5 0.04
6 months 27.2 ± 19.2 19.9 ± 17.8 0.07
12 months 24.4 ± 20.6 16.3 ± 16.4 0.04
24 months 17.8 ± 15.2 16.7 ± 16.2 0.75
VAS arm
3 months 26.4 ± 27.7 28.7 ± 31.7 0.72
6 months 29.4 ± 32.4 21.5 ± 28.5 0.24
12 months 33.0 ± 31.9 20.5 ± 26.3 0.04
24 months 27.4 ± 28.4 17.3 ± 21.7 0.06
VAS neck
3 months 32.2 ± 27.8 29.5 ± 26.3 0.65
6 months 33.2 ± 31.0 20.4 ± 23.2 0.03
12 months 26.3 ± 24.9 22.4 ± 26.8 0.48
24 months 18.6 ± 23.6 17.9 ± 21.1 0.88
SF-36 physical functioning
3 months 68.6 ± 24.3 73.5 ± 22.4 0.33
6 months 73.3 ± 24.1 74.9 ± 25.0 0.77
12 months 75.7 ± 23.8 79.3 ± 21.9 0.45
24 months 78.4 ± 21.7 77.6 ± 27.5 0.88
SF-36 bodily pain
3 months 54.8 ± 24.5 66.4 ± 21.1 0.02
6 months 57.2 ± 25.6 67.0 ± 25.1 0.07
12 months 63.4 ± 25.4 67.3 ± 25.8 0.46
24 months 73.4 ± 24.0 71.8 ± 25.3 0.76
Surgeons perceived recovery
3 months 68.0 83.0 0.10
6 months 67.4 77.8 0.35
12 months 70.2 80.4 0.38
24 months 80.4 86.7 0.57
Patient perceived recovery
3 months 58.3 65.2 0.53
6 months 57.8 70.5 0.27
12 months 58.7 76.1 0.12
24 months 78.3 88.1 0.26
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many US studies incorporate allograft blocks with supple-
mental fixation as the control group.However, theCASCADE
clinical trial represents the worst-case scenario because
autograft results in higher fusion rates than allograft. Finally,
the study was supported financially by the company Amedica
that is the manufacturer of silicon nitride. Every effort was
made to eliminate bias in the study design, protocol, and
management of the study. Independent Clinical Research
Organization (CRO) managed the study together with the
principal investigator’s institution, the radiographic mea-
surements were also performed by an independent organiza-
tion employing their radiologists and yet another independent
unit was used to perform statistical analysis. With those pre-
cautions, the authors have implemented reasonable procedure
to minimize bias.
In conclusion, patients with symptomatic herniated disc
or spondylosis treated with anterior cervical discectomy
and interbody fusion using silicon nitride or PEEK reported
similar recovery rates. There was no significant difference
in clinical outcome at 24 months, although some interme-
diate outcome measures were in favor of PEEK but did not
reach the level of clinical relevance. Fusion rates of both
implants improve over time and no significant difference
was seen regarding fusion and subsidence. The primary
hypothesis of similarity in NDI improvement between sil-
icon nitride and PEEK has been proven.
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Fig. 3 Fusion rate defined as rotation B4 and B1.25 mm translation
on flexion–extension films on dynamic X-ray. In both groups the
fusion rate increased over time and there was no significant difference
between both groups















Mean 1.48 1.59 0.33





Silicon nitride (N = 52) PEEK (N = 48) p value
Operative characteristics
Operative time, min (range) 42.0 (25–65) 40.6 (30–60) 0.41
Blood loss, ml (range) 107 (10–600) 109 (10–800) 0.95
Mean hospital stay, days (range) 1.1 (1–3) 1.0 (1–2) 0.17
Complications
Transient dysphagia 9 8 0.70
Cage subsidence with revision surgery 1 1 1.00
Infection with cage removal 1 0 1.00
Adjacent level surgery 6 3 0.49
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